SCHEMBL6207847

SCHEMBL6207847

[NH]NC(=O)[C@H]1CCC(=O)N1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
POLB P06746 1/20 0.46
GAA P10253 1/20 0.36
LMNA P02545 1/20 0.35
HPGDS O60760 1/20 0.35
NAMPT P43490 3/20 0.34
PARP1 P09874 2/20 0.34
TSHR P16473 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8213580 0.82 SMN1; SMN2 (0.49) SMN1; SMN2MEN1KMT2APOLBGAA
SCHEMBL13451733 0.80 SMN1; SMN2 (0.48) SMN1; SMN2MEN1KMT2APOLBGAA
SCHEMBL2568385 0.80 SMN1; SMN2 (0.48) SMN1; SMN2MEN1KMT2APOLBGAA
SCHEMBL10820749 0.80 SMN1; SMN2 (0.48) SMN1; SMN2MEN1KMT2APOLBGAA
SCHEMBL2567250 0.80 SMN1; SMN2 (0.48) SMN1; SMN2MEN1KMT2APOLBGAA
SCHEMBL85699 0.80 SMN1; SMN2 (0.48) SMN1; SMN2MEN1KMT2APOLBGAA
SCHEMBL2827980 0.80 SMN1; SMN2 (0.48) SMN1; SMN2MEN1KMT2APOLBGAA
SCHEMBL2822724 0.80 SMN1; SMN2 (0.48) SMN1; SMN2MEN1KMT2APOLBGAA
SCHEMBL2823436 0.80 SMN1; SMN2 (0.48) SMN1; SMN2MEN1KMT2APOLBGAA
SCHEMBL2570631 0.80 SMN1; SMN2 (0.48) SMN1; SMN2MEN1KMT2APOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1606268-A1 HETEROCYCLIC KINASE INHIBITORS Abbott Laboratories (US) 2005-12-21 EP disclosed
WO-2004076424-A1 HETEROCYCLIC KINASE INHIBITORS ABBOTT LABORATORIES (US) 2004-09-10 WO disclosed